John Philip Kostuik M.D., Chief Medical Officer at K2M GROUP HOLDINGS, INC. (KTWO), sold 1,090 shares at $24.08 ($26K) on 2017-08-15, disclosed to the SEC on 2017-08-16.
Scheduled sale ($26k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KTWO | SELL | 2017-01-24 | $629K | — | Filing → |
| KTWO | SELL | 2017-01-19 | $2.1M | — | Filing → |
| KTWO | SELL | 2015-06-24 | $605K | — | Filing → |